Cargando…

Drug metabolism‐related eight‐gene signature can predict the prognosis of gastric adenocarcinoma

BACKGROUND: Metabolic abnormalities in patients with gastric adenocarcinoma lead to drug resistance and poor prognosis. Therefore, this study aimed to explore biomarkers that can predict the prognostic risk of gastric adenocarcinoma by analyzing drug metabolism‐related genes. METHODS: The RNA‐seq an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Hong‐mei, He, Qiong, Chen, Jia, Li, Zhen, Yang, Wanli, Hu, Xiaobo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649372/ https://www.ncbi.nlm.nih.gov/pubmed/34773716 http://dx.doi.org/10.1002/jcla.24085

Ejemplares similares

Immune‐related eight‐lncRNA signature for improving prognosis prediction of lung adenocarcinoma
por: Chen, Yan, et al.
Publicado: (2021)

Hypoxia-Related Gene-Based Signature Can Evaluate the Tumor Immune Microenvironment and Predict the Prognosis of Colon Adenocarcinoma Patients
por: He, Xiaobo, et al.
Publicado: (2021)

Establishment and validation of an eight-gene metabolic–related prognostic signature model for lung adenocarcinoma
por: Ma, Weishuang, et al.
Publicado: (2021)

Identification of an eight-gene prognostic signature for lung adenocarcinoma
por: Li, Shicheng, et al.
Publicado: (2018)

A panel of eight mRNA signatures improves prognosis prediction of osteosarcoma patients
por: Wu, Bo, et al.
Publicado: (2021)

Identification of a Novel Tumor Microenvironment–Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2020)

An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
por: Zhao, Xiaowen, et al.
Publicado: (2022)

Metabolism‐related lncRNAs signature to predict the prognosis of colon adenocarcinoma
por: Sun, Yimin, et al.
Publicado: (2022)

A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
por: Wang, Li, et al.
Publicado: (2022)

An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma
por: Li, Xuelian, et al.
Publicado: (2014)

Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients
por: Zheng, Yang, et al.
Publicado: (2022)

A prediction model for prognosis of gastric adenocarcinoma based on six metabolism-related genes
por: Zhao, Jingyu, et al.
Publicado: (2023)

The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction
por: Tan, Zhen, et al.
Publicado: (2020)

Lipid metabolism-related gene signatures for predicting the prognosis of lung adenocarcinoma
por: Cao, Xueting, et al.
Publicado: (2023)

Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer
por: Wu, Xin, et al.
Publicado: (2022)

A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
por: Wang, Xuewen, et al.
Publicado: (2022)

Exploration of a Novel Circadian miRNA Pair Signature for Predicting Prognosis of Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
por: Zhu, Rui, et al.
Publicado: (2019)

An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma
por: Gong, Zhenyu, et al.
Publicado: (2020)

Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma
por: Zou, Zhengrong, et al.
Publicado: (2022)

A novel APA-based prognostic signature may predict the prognosis of lung adenocarcinoma in an East Asian population
por: Zhang, Wendi, et al.
Publicado: (2023)

Prognosis Implication of a Novel Metabolism-Related Gene Signature in Ewing Sarcoma
por: Chen, Zhuo-Yuan, et al.
Publicado: (2021)

Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma
por: Xu, Peipei, et al.
Publicado: (2023)

FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma
por: Zhang, Zeyu, et al.
Publicado: (2021)

Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
por: Zhang, Jia-Le, et al.
Publicado: (2023)

Eight potential biomarkers for distinguishing between lung adenocarcinoma and squamous cell carcinoma
por: Xiao, Jian, et al.
Publicado: (2017)

The Pattern of Signatures in Gastric Cancer Prognosis
por: Machlowska, Julita, et al.
Publicado: (2018)

ImmuneScore of eight-gene signature predicts prognosis and survival in patients with endometrial cancer
por: Gu, Jiahui, et al.
Publicado: (2023)

Development of a Signature Based on Eight Metastatic-Related Genes for Prognosis of GC Patients
por: Shang, Fanjing, et al.
Publicado: (2023)

Identification of an Amino Acid Metabolism-Related Gene Signature for Predicting Prognosis in Lung Adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2022)

An Inflammatory Response-Related Gene Signature Can Predict the Prognosis and Impact the Immune Status of Lung Adenocarcinoma
por: Shi, Yubo, et al.
Publicado: (2022)

NF-κB-Related Metabolic Gene Signature Predicts the Prognosis and Immunotherapy Response in Gastric Cancer
por: Chen, Qiuxiang, et al.
Publicado: (2022)

Genome-Wide Analysis of Methylation-Driven Genes and Identification of an Eight-Gene Panel for Prognosis Prediction in Breast Cancer
por: Kuang, Yanshen, et al.
Publicado: (2020)

Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma
por: Yang, Mian, et al.
Publicado: (2022)

A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Tang, Xiaolong, et al.
Publicado: (2022)

Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

A novel methionine metabolism-related signature predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Qing-Hua, et al.
Publicado: (2023)

A cuproptosis-related signature for predicting the prognosis of gastric cancer
por: He, Chunmei, et al.
Publicado: (2023)

Eight Aging-Related Genes Prognostic Signature for Cervical Cancer
por: Yin, Meilin, et al.
Publicado: (2023)

Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis
por: Yao, Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ld8mnv4jj15juch3ebk45bjng3